A carregar...

Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer

BACKGROUND: Increasing evidence supporting the role of immune checkpoint blockade in cancer management has been bolstered by recent reports demonstrating significant and durable clinical responses across multiple tumour types, including metastatic urothelial carcinoma (mUC). The majority of these re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bl Cancer
Main Authors: Bidnur, S., Savdie, R., Black, P.C.
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4927995/
https://ncbi.nlm.nih.gov/pubmed/27376121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-150026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!